Cristina Parisi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cristina Parisi has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Salvatore Sortino
PhotoChemLab, Department of Drug and Health Sciences, University of Catania, I-95125, Italy
16 shared publications - Aurore Fraix
PhotoChemLab, Department of Drug and Health Sciences, University of Catania, I-95125 Catania, Italy
5 shared publications Alberto Gasco
Department of Science and Drug Technology, University of Torino, I-10125 Torino, Italy
4 shared publicationsFrancesca Laneri
PhotoChemLab, Department of Drug and Health Sciences
4 shared publications- Francesca Laneri
PhotoChemLab, Department of Drug and Health Sciences, University of Catania, I-95125, Italy
4 shared publications - Mariacristina Failla
Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy
4 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (46) , 60622-60630
Boosted stepwise NO photorelease with overall fluorescent reporting in a molecular dyad for antimicrobial photoinactivation
Sequential and amplified NO release with fluorescent self-reporting is achieved with photoactivatable molecular dyad exhibiting strong antibacterial actions against Gram positive and Gram negative bacteria.
- 21 October 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (46) , 60622-60630
Open AccessBoosted stepwise NO photorelease with overall fluorescent reporting in a molecular dyad for antimicrobial photoinactivation
Sequential and amplified NO release with fluorescent self-reporting is achieved with photoactivatable molecular dyad exhibiting strong antibacterial actions against Gram positive and Gram negative bacteria.
- Open Access
- 12 October 2026
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 37 (10) , 2084-2091
Porphyrin−Peptide Bioconjugates: Photophysical Properties and Targeted Singlet Oxygen-Mediated Photooxidation of Amyloid-β
The aberrant self-assembly of amyloid β (Aβ) peptides into toxic oligomers is a central event in Alzheimer’s disease, motivating the development of molecular systems capable of modulating or degrading these species. Porphyrins and porphyrin−peptide bioconjugates have emerged as promising photoactive platforms due to their known ability to generate the highly oxidant singlet oxygen (1O2) upon light excitation. Still, the mechanisms underlying their oxidative effects on Aβ remain unclear. Here, we investigate the photophysical properties and the 1O2-mediated oxidation capability of two porphyrin−peptide conjugates, Ph-Pep and its Zn-metallated analogue ZnPh-Pep, both incorporating the Aβ recognition motif KLVFF. Steady-state and time-resolved spectroscopic studies reveal the good preservation of the photophysical and photochemical properties of the porphyrin chromophore units after their conjugation with the peptide appendage. Population of the long-lived triplet state of both compounds under visible-light excitation results in an effective generation of 1O2. High-resolution mass spectrometry shows that the 1O2 photogenerated by ZnPh-Pep induces extensive oxidation, yielding peroxidic and hydroperoxidic species, and provides evidence of partial Aβ42 degradation. In contrast, Ph-Pep leads to a rapid loss of detectable Aβ signal, suggesting the formation of higher-order aggregates rather than peptide cleavage. These distinct outcomes highlight the roles of Zn2+ coordination and peptide conjugation in modulating the 1O2-driven pathways. Overall, this study provides a mechanistic insight into designing photoactivatable porphyrin-based constructs capable of degrading or modulating toxic Aβ assemblies, opening intriguing prospects for light-mediated therapeutic strategies for neurodegenerative diseases.
- 12 October 2026
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 37 (10) , 2084-2091
Open AccessPorphyrin−Peptide Bioconjugates: Photophysical Properties and Targeted Singlet Oxygen-Mediated Photooxidation of Amyloid-β
The aberrant self-assembly of amyloid β (Aβ) peptides into toxic oligomers is a central event in Alzheimer’s disease, motivating the development of molecular systems capable of modulating or degrading these species. Porphyrins and porphyrin−peptide bioconjugates have emerged as promising photoactive platforms due to their known ability to generate the highly oxidant singlet oxygen (1O2) upon light excitation. Still, the mechanisms underlying their oxidative effects on Aβ remain unclear. Here, we investigate the photophysical properties and the 1O2-mediated oxidation capability of two porphyrin−peptide conjugates, Ph-Pep and its Zn-metallated analogue ZnPh-Pep, both incorporating the Aβ recognition motif KLVFF. Steady-state and time-resolved spectroscopic studies reveal the good preservation of the photophysical and photochemical properties of the porphyrin chromophore units after their conjugation with the peptide appendage. Population of the long-lived triplet state of both compounds under visible-light excitation results in an effective generation of 1O2. High-resolution mass spectrometry shows that the 1O2 photogenerated by ZnPh-Pep induces extensive oxidation, yielding peroxidic and hydroperoxidic species, and provides evidence of partial Aβ42 degradation. In contrast, Ph-Pep leads to a rapid loss of detectable Aβ signal, suggesting the formation of higher-order aggregates rather than peptide cleavage. These distinct outcomes highlight the roles of Zn2+ coordination and peptide conjugation in modulating the 1O2-driven pathways. Overall, this study provides a mechanistic insight into designing photoactivatable porphyrin-based constructs capable of degrading or modulating toxic Aβ assemblies, opening intriguing prospects for light-mediated therapeutic strategies for neurodegenerative diseases.
- Open Access
- 8 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 9 (28) , 13577-13588
β-Cyclodextrin-Coated N -Doped Carbon Dots for Red-Light-Controlled Nitric Oxide Release and Photothermal Therapy
- 8 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 9 (28) , 13577-13588
Open Accessβ-Cyclodextrin-Coated N -Doped Carbon Dots for Red-Light-Controlled Nitric Oxide Release and Photothermal Therapy
- Open Access
- 15 April 2026
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 27 (5) , 3399-3409
Phototherapeutic β-Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin
In this contribution, we report the design, synthesis, photochemical characterization, and biological validation of a novel, photoresponsive β-cyclodextrin branched polymer (Poly-βCD1) and its nanoassembly with doxorubicin (DOX). This tailored polymer covalently integrates multiple bichromophoric dyads based on nitroaniline- and coumarin-derived motifs within its macromolecular scaffold. Excitation of the Poly-βCD1 with visible blue light results in the generation of nitric oxide (NO) from the nitroaniline moiety, and the parallel restoration of the typical emission of the coumarin fluorogenic unit, initially suppressed by Förster Resonance Energy Transfer (FRET), which acts as an optical self-reporter for the photoreleased NO. These photochemical properties are enhanced relative to those of the isolated monomer βCD1, synthesized as a model compound, and are well preserved after DOX entrapment within the polymeric network. This feature enables real-time optical monitoring of the NO photodelivery in cancer cells using fluorescence microscopy. Preliminary toxicity experiments carried out with DOX-sensitive and DOX-resistant cancer cells demonstrate that Poly-βCD1 is well tolerated in the dark but induces cell death under light irradiation. Besides, the negligible cytotoxic action of DOX, used well below the therapeutic doses, alone or in combination with the polymer in the dark, is enhanced in both cell lines under light irradiation exclusively when the drug is combined with Poly-βCD1 as a result of the combined action of NO.
- 15 April 2026
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 27 (5) , 3399-3409
Open AccessPhototherapeutic β-Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin
In this contribution, we report the design, synthesis, photochemical characterization, and biological validation of a novel, photoresponsive β-cyclodextrin branched polymer (Poly-βCD1) and its nanoassembly with doxorubicin (DOX). This tailored polymer covalently integrates multiple bichromophoric dyads based on nitroaniline- and coumarin-derived motifs within its macromolecular scaffold. Excitation of the Poly-βCD1 with visible blue light results in the generation of nitric oxide (NO) from the nitroaniline moiety, and the parallel restoration of the typical emission of the coumarin fluorogenic unit, initially suppressed by Förster Resonance Energy Transfer (FRET), which acts as an optical self-reporter for the photoreleased NO. These photochemical properties are enhanced relative to those of the isolated monomer βCD1, synthesized as a model compound, and are well preserved after DOX entrapment within the polymeric network. This feature enables real-time optical monitoring of the NO photodelivery in cancer cells using fluorescence microscopy. Preliminary toxicity experiments carried out with DOX-sensitive and DOX-resistant cancer cells demonstrate that Poly-βCD1 is well tolerated in the dark but induces cell death under light irradiation. Besides, the negligible cytotoxic action of DOX, used well below the therapeutic doses, alone or in combination with the polymer in the dark, is enhanced in both cell lines under light irradiation exclusively when the drug is combined with Poly-βCD1 as a result of the combined action of NO.
- Open Access
- 16 December 2025
- Published by American Chemical Society (ACS) in Chemical & Biomedical Imaging
- Vol. 4 (5) , 846-853
A Molecular Hybrid for Double Stepwise Nitric Oxide Photorelease with Double Fluorescence Readout in Living Cells
The strict dependence of the multifaceted biological effects of nitric oxide (NO) on the generation site and dose demands precise spatiotemporal control of its delivery. Light-activatable NO precursors enable this requirement by allowing for the appropriate localization of the excitation light source on the area of interest and regulation of the light dose. However, monitoring the NO released in living cells with the aid of noninvasive fluorescence techniques, without the use of additional NO probes, is very challenging for the bioapplications of this inorganic free radical. We report herein the design, synthesis, characterization, and biological validation of a molecular hybrid consisting of two chromogenic nitroso-derivatives covalently joined through a flexible alkyl spacer, which can release two NO molecules exclusively under visible light input through a stepwise mechanism accompanied by a double fluorescence readout. Specifically, the two distinct NO release processes are paralleled by a turn-on and turn-off of the green fluorescence of the corresponding stable coproducts, respectively, which act as optical NO reporters. This feature permits monitoring of the two individual steps of NO photouncaging in real time by fluorescence spectroscopy. Proof-of-principle fluorescence microscopy experiments demonstrate that, not trivially, the photochemical properties of the hybrid are well-preserved in living cancer cells, where the stepwise release of NO can be imaged in real time without the use of additional chemical probes. This makes the present compound an intriguing candidate for fundamental and potential applicative research studies, where the short- and long-term release of spatiotemporally controlled NO delivery, associated with its direct optical detection, is required.
- 16 December 2025
- Published by American Chemical Society (ACS) in Chemical & Biomedical Imaging
- Vol. 4 (5) , 846-853
Open AccessA Molecular Hybrid for Double Stepwise Nitric Oxide Photorelease with Double Fluorescence Readout in Living Cells
The strict dependence of the multifaceted biological effects of nitric oxide (NO) on the generation site and dose demands precise spatiotemporal control of its delivery. Light-activatable NO precursors enable this requirement by allowing for the appropriate localization of the excitation light source on the area of interest and regulation of the light dose. However, monitoring the NO released in living cells with the aid of noninvasive fluorescence techniques, without the use of additional NO probes, is very challenging for the bioapplications of this inorganic free radical. We report herein the design, synthesis, characterization, and biological validation of a molecular hybrid consisting of two chromogenic nitroso-derivatives covalently joined through a flexible alkyl spacer, which can release two NO molecules exclusively under visible light input through a stepwise mechanism accompanied by a double fluorescence readout. Specifically, the two distinct NO release processes are paralleled by a turn-on and turn-off of the green fluorescence of the corresponding stable coproducts, respectively, which act as optical NO reporters. This feature permits monitoring of the two individual steps of NO photouncaging in real time by fluorescence spectroscopy. Proof-of-principle fluorescence microscopy experiments demonstrate that, not trivially, the photochemical properties of the hybrid are well-preserved in living cancer cells, where the stepwise release of NO can be imaged in real time without the use of additional chemical probes. This makes the present compound an intriguing candidate for fundamental and potential applicative research studies, where the short- and long-term release of spatiotemporally controlled NO delivery, associated with its direct optical detection, is required.
- Open Access
- 3 July 2025
- Published by Beilstein Institut in Beilstein Journal of Nanotechnology
- Vol. 16 (1) , 1003-1013
A calix[4]arene-based supramolecular nanoassembly targeting cancer cells and triggering the release of nitric oxide with green light
We have designed and synthesized a novel calix[4]arene derivative bearing four choline appendages as recognition targeting ligands and one amino-nitrobenzofurazan as a fluorescent labelling unit at the opposite sides of the calixarene molecular scaffold. Due to its amphiphilic character, this compound is well soluble in water, forming supramolecular assemblies that are ca. 170 nm in diameter. The nanoassembly selectively targets cancer cells that overexpress the choline transporters, and it can be visualized thanks to the fluorescent tag. The fluorogenic unit also acts as a green light harvesting center, making the nanoassembly a photo-nanoreactor able to encapsulate a hydrophobic nitric oxide (NO) photodonor, otherwise activatable with blue light, and encouraging the NO release with the more biocompatible green light probably by an intra-cage photoinduced electron transfer.
- 3 July 2025
- Published by Beilstein Institut in Beilstein Journal of Nanotechnology
- Vol. 16 (1) , 1003-1013
Open AccessA calix[4]arene-based supramolecular nanoassembly targeting cancer cells and triggering the release of nitric oxide with green light
We have designed and synthesized a novel calix[4]arene derivative bearing four choline appendages as recognition targeting ligands and one amino-nitrobenzofurazan as a fluorescent labelling unit at the opposite sides of the calixarene molecular scaffold. Due to its amphiphilic character, this compound is well soluble in water, forming supramolecular assemblies that are ca. 170 nm in diameter. The nanoassembly selectively targets cancer cells that overexpress the choline transporters, and it can be visualized thanks to the fluorescent tag. The fluorogenic unit also acts as a green light harvesting center, making the nanoassembly a photo-nanoreactor able to encapsulate a hydrophobic nitric oxide (NO) photodonor, otherwise activatable with blue light, and encouraging the NO release with the more biocompatible green light probably by an intra-cage photoinduced electron transfer.
- Open Access
- 16 June 2025
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 8 (25) , 13083-13091
N-Doped Carbon Dot-Based Nanoconjugates with Simultaneous Generation of Nitric Oxide and Singlet Oxygen for Phototherapeutic Applications
Nitric oxide (NO) and singlet oxygen (1O2) represent two of the most intriguing agents for unconventional phototherapeutic applications in cancer. In this contribution, N-doped carbon dots (NCDs) with strong absorption in the biocompatible green region have been synthesized and covalently decorated with an otherwise blue-light-activatable NO photodonor (NOPD), leading to a nanoconjugate ca. 3.5 nm in diameter. The NCD core of the nanoconstruct acts as a green light antenna, permitting the release of NO from the NOPD by an intramolecular photoinduced electron transfer, with an improvement of more than 100 nm in the excitation wavelength. Simultaneously, green light excitation generates 1O2 by collisional energy transfer with molecular oxygen. Due to its emissive properties, the nanoconjugate can be visualized in 9L/LacZ brain cancer cells, where it localizes mainly in the cytoplasm. Amplified mortality of cancer cells is observed upon green light irradiation due to the mutual photodynamic action of NO and 1O2.
- 16 June 2025
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 8 (25) , 13083-13091
Open AccessN-Doped Carbon Dot-Based Nanoconjugates with Simultaneous Generation of Nitric Oxide and Singlet Oxygen for Phototherapeutic Applications
Nitric oxide (NO) and singlet oxygen (1O2) represent two of the most intriguing agents for unconventional phototherapeutic applications in cancer. In this contribution, N-doped carbon dots (NCDs) with strong absorption in the biocompatible green region have been synthesized and covalently decorated with an otherwise blue-light-activatable NO photodonor (NOPD), leading to a nanoconjugate ca. 3.5 nm in diameter. The NCD core of the nanoconstruct acts as a green light antenna, permitting the release of NO from the NOPD by an intramolecular photoinduced electron transfer, with an improvement of more than 100 nm in the excitation wavelength. Simultaneously, green light excitation generates 1O2 by collisional energy transfer with molecular oxygen. Due to its emissive properties, the nanoconjugate can be visualized in 9L/LacZ brain cancer cells, where it localizes mainly in the cytoplasm. Amplified mortality of cancer cells is observed upon green light irradiation due to the mutual photodynamic action of NO and 1O2.
- Open Access
- 18 April 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (15) , e2500589
Light‐Activatable Hyaluronic Acid‐Derivatives Releasing Nitric Oxide and Their Delivery in the Skin
Hyaluronic acid (HA), renowned for its hydrating properties, penetrates deeper into the skin at a very low molecular weight, promoting cellular repair and reducing inflammation. Nitric oxide (NO), a gaseous mediator with a very relevant role in many physiological and pathophysiological processes, is expected to complement the functions of HA in the skin through its vasodilatory, anti‐inflammatory, and regenerative properties. Herein, a novel class of HA derivatives functionalized with NO photodonors (NOPD) for light‐activated therapeutic applications is introduced. The HA derivatives HA‐NOPD1 and HA‐NOPD2 demonstrated NO release under blue light activation. Biological assays on HaCaT keratinocytes revealed enhanced proliferation and migration under light stimuli, underscoring the therapeutic potential of HA‐NOPD1. The derivatives are formulated into microemulsions (MEs) to allow their skin transport. MEs loaded with the photoresponsive derivatives are stable in the dark and provide effective NO photorelease with higher quantum yields than the free compounds. Skin permeation studies using porcine and artificial membranes confirmed that HA‐NOPD2 distributed in all the skin layers, reaching the dermis and releasing NO in situ.
- 18 April 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (15) , e2500589
Open AccessLight‐Activatable Hyaluronic Acid‐Derivatives Releasing Nitric Oxide and Their Delivery in the Skin
Hyaluronic acid (HA), renowned for its hydrating properties, penetrates deeper into the skin at a very low molecular weight, promoting cellular repair and reducing inflammation. Nitric oxide (NO), a gaseous mediator with a very relevant role in many physiological and pathophysiological processes, is expected to complement the functions of HA in the skin through its vasodilatory, anti‐inflammatory, and regenerative properties. Herein, a novel class of HA derivatives functionalized with NO photodonors (NOPD) for light‐activated therapeutic applications is introduced. The HA derivatives HA‐NOPD1 and HA‐NOPD2 demonstrated NO release under blue light activation. Biological assays on HaCaT keratinocytes revealed enhanced proliferation and migration under light stimuli, underscoring the therapeutic potential of HA‐NOPD1. The derivatives are formulated into microemulsions (MEs) to allow their skin transport. MEs loaded with the photoresponsive derivatives are stable in the dark and provide effective NO photorelease with higher quantum yields than the free compounds. Skin permeation studies using porcine and artificial membranes confirmed that HA‐NOPD2 distributed in all the skin layers, reaching the dermis and releasing NO in situ.
- Open Access
- 3 March 2025
- Published by Beilstein Institut in Beilstein Archives
- Vol. 2025 (1) , 13
A calix[4]arene-based supramolecular nanoassembly targeting cancer cells and triggering the release of nitric oxide with green light
We have designed and synthesized a novel calix[4]arene derivative bearing four choline appendages, as recognition targeting ligands, and one amino-nitrobenzofurazan, as a fluorescent labeling unit, at the opposite sides of the calixarene molecular scaffold. Due to its amphiphilic character, this compound is well soluble in water, forming supramolecular assemblies that are ca. 170 nm in diameter. The nanoassembly selectively targets cancer cells that overexpress the choline receptors, and it can be visualized thanks to the fluorescent tag. The fluorogenic unit also acts as a green light harvesting center, making the nanoassembly a photo-nanoreactor able to encapsulate a hydrophobic nitric oxide (NO) photodonor, otherwise activatable with blue light, and encouraging the NO release with the more biocompatible green light probably by an intra-cage photoinduced electron transfer.
- 3 March 2025
- Published by Beilstein Institut in Beilstein Archives
- Vol. 2025 (1) , 13
Open AccessA calix[4]arene-based supramolecular nanoassembly targeting cancer cells and triggering the release of nitric oxide with green light
We have designed and synthesized a novel calix[4]arene derivative bearing four choline appendages, as recognition targeting ligands, and one amino-nitrobenzofurazan, as a fluorescent labeling unit, at the opposite sides of the calixarene molecular scaffold. Due to its amphiphilic character, this compound is well soluble in water, forming supramolecular assemblies that are ca. 170 nm in diameter. The nanoassembly selectively targets cancer cells that overexpress the choline receptors, and it can be visualized thanks to the fluorescent tag. The fluorogenic unit also acts as a green light harvesting center, making the nanoassembly a photo-nanoreactor able to encapsulate a hydrophobic nitric oxide (NO) photodonor, otherwise activatable with blue light, and encouraging the NO release with the more biocompatible green light probably by an intra-cage photoinduced electron transfer.
- 24 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (44) , 59697-59720
Nitric Oxide-Photodelivering Materials with Multiple Functionalities: From Rational Design to Therapeutic Applications
The achievement of materials that are able to release therapeutic agents under the control of light stimuli to improve therapeutic efficacy is a significant challenge in health care. Nitric oxide (NO) is one of the most studied molecules in the fascinating realm of biomedical sciences, not only for its crucial role as a gaseous signaling molecule in the human body but also for its great potential as an unconventional therapeutic in a variety of diseases including cancer, bacterial and viral infections, and neurodegeneration. Handling difficulties due to its gaseous nature, reduced region of action due to its short half-life, and strict dependence of the biological effects on its concentration and generation site are critical questions to be solved for appropriate therapeutic uses of NO. Light-activatable NO precursors, namely, NO photodonors (NOPDs), address the above issues since they are stable in the dark and permit in a noninvasive fashion the remote-controlled delivery of NO on demand with great spatiotemporal precision. Engineering biocompatible materials with NOPDs and their combination with additional imaging, therapeutic, and phototherapeutic components leads to intriguing light-responsive multifunctional constructs exhibiting promising potential for biomedical applications. This contribution illustrates the most significant progress made over the last five years in achieving engineered materials including nanoparticles, gels, and thin films, sharing the common feature to deliver NO under the exclusive control of the biocompatible visible/near infrared light inputs. We will highlight the logical design behind the fabrication of these systems, illustrating the potential therapeutic applications with particular emphasis on cancer and bacterial infections.
- 24 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (44) , 59697-59720
Nitric Oxide-Photodelivering Materials with Multiple Functionalities: From Rational Design to Therapeutic Applications
The achievement of materials that are able to release therapeutic agents under the control of light stimuli to improve therapeutic efficacy is a significant challenge in health care. Nitric oxide (NO) is one of the most studied molecules in the fascinating realm of biomedical sciences, not only for its crucial role as a gaseous signaling molecule in the human body but also for its great potential as an unconventional therapeutic in a variety of diseases including cancer, bacterial and viral infections, and neurodegeneration. Handling difficulties due to its gaseous nature, reduced region of action due to its short half-life, and strict dependence of the biological effects on its concentration and generation site are critical questions to be solved for appropriate therapeutic uses of NO. Light-activatable NO precursors, namely, NO photodonors (NOPDs), address the above issues since they are stable in the dark and permit in a noninvasive fashion the remote-controlled delivery of NO on demand with great spatiotemporal precision. Engineering biocompatible materials with NOPDs and their combination with additional imaging, therapeutic, and phototherapeutic components leads to intriguing light-responsive multifunctional constructs exhibiting promising potential for biomedical applications. This contribution illustrates the most significant progress made over the last five years in achieving engineered materials including nanoparticles, gels, and thin films, sharing the common feature to deliver NO under the exclusive control of the biocompatible visible/near infrared light inputs. We will highlight the logical design behind the fabrication of these systems, illustrating the potential therapeutic applications with particular emphasis on cancer and bacterial infections.